ROCKET PHARMACEUTICALS, INC.
Pharmaceutical company seeking gene therapy for rare diseases
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report (No Activity) 3rd Quarter 2026
|
THE KPM GROUP DC LLC | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2026
|
THE KPM GROUP DC LLC | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2026
|
THE KPM GROUP DC LLC | $30,000 reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2025
|
THE KPM GROUP DC LLC | $30,000 reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2025
|
THE KPM GROUP DC LLC | $30,000 reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2025
|
THE KPM GROUP DC LLC | $30,000 reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2025
|
THE KPM GROUP DC LLC | $20,000 reported |
|
4th Quarter - Amendment 4th Quarter 2024
|
THE KPM GROUP DC LLC | $30,000 reported |
|
Registration 4th Quarter 2024
|
THE KPM GROUP DC LLC | — reported |
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2022
|
MERCURY PUBLIC AFFAIRS, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE KPM GROUP DC LLC | 8 | $170,000 |
| MAYER BROWN LLP | 5 | $110,000 |
| MERCURY PUBLIC AFFAIRS, LLC | 7 | $50,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 7 |
| Immigration | IMM | 5 |
| Pharmacy | PHA | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.